Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 901 to 925 of about 5861

Previous 25

Website Changes

04/02/2020

Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma.

04/02/2020

Phase I/II Clinical Study of ONC201 Begins in Japan

03/31/2020

UF brain tumor researcher embarks on first-in-human clinical trial of novel immunotherapy vaccine

03/30/2020

Musella Foundation Webinar Series

03/30/2020

03/28/2020

Stimulus plan: Changes to charitable contributions!

03/28/2020

12 medical centers form brain tumor research collaborative

03/20/2020

Young girl with incurable tumour may not receive lifeline treatment in New York

03/20/2020

German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany

03/19/2020

5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the Two Techniques to Optimize the Extent of Resection in Glioblastoma Surgery

03/16/2020

Researchers Uncover Racial Disparities in Brain Cancer Outcomes

03/16/2020

Rindopepimut With Bevacizumab for Patients With Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

03/14/2020

Intraoperative MRI versus 5-ALA in high-grade glioma resection: a network meta-analysis

03/14/2020

First-line Bevacizumab Contributes to Survival Improvement in Glioblastoma Patients Complementary to Temozolomide

03/14/2020

Tamoxifen Is a Candidate First-In-Class Inhibitor of Acid Ceramidase That Reduces Amitotic Division in Polyploid Giant Cancer cells-Unrecognized Players in Tumorigenesis

03/14/2020

Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial

03/14/2020

Ketogenic Diets as an Adjuvant Therapy for Glioblastoma (KEATING): A Randomized, Mixed Methods, Feasibility Study

03/13/2020

Optune Open Houses are now availble as webinars!

03/12/2020

Preclinical Data Show Tumor Treating Fields Induces Immunogenic Cell Death Resulting in Enhanced Antitumor Efficacy When Combined with Anti-PD-1 Therapy

03/10/2020

An innovative drug trial for brain cancer begins at UAB

02/20/2020

The American Brain Tumor Association’s 2020 Regional Patient and Family Meeting is coming to New York!

02/19/2020

DelMar Pharmaceuticals [Nasdaq:DMPI] Enrolls Final Patient in Phase 2 Clinical Trial of VAL-083 For First-Line Treatment of Brain Tumors

02/18/2020

Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma

02/14/2020

Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy.

02/13/2020

DIPG / DMG Registry Family Update Webinar

Our privacy / cookie policy has changed.
Click HERE to read it!